# kentathlonepharmagroup.com

> AI-optimized mirror of kentathlonepharmagroup.com containing 41 pages totalling 19,582 words of clean markdown content, structured data, and semantic HTML. Original source: https://kentathlonepharmagroup.com. Last updated: 2026-08-28T02:10:02.933Z.

Each page is available as HTML (with JSON-LD structured data) and Markdown (text-only, ideal for LLMs and RAG).

## Homepage

- [Kent-Athlone Pharma Group - A European Specialty Pharmaceutical Company.](/content/site-root.html): Our strategic focus is on developing, in-licensing, acquiring and commercialising value-added medicines. (193 words)

## Articles & Blog Posts

- [wp-content/uploads/2026/06/kag-carbon-reduction-plan-2026-part-1-signed-pdf.html](/content/wp-content/uploads/2026/06/kag-carbon-reduction-plan-2026-part-1-signed-pdf.html) (1,537 words)
- [contact-kent-pharma/index.html](/content/contact-kent-pharma/index.html) (227 words)
- [wp-content/uploads/2024/05/modern-slavery-human-trafficking-statement-oct2024-pdf.html](/content/wp-content/uploads/2024/05/modern-slavery-human-trafficking-statement-oct2024-pdf.html) (1,901 words)
- [About Us - Kent-Athlone Pharma Group](/content/company-profile/index.html): The Kent-Athlone Pharma Group has a strong network of over 50 international partners , enabling us to collaborate and support customers and suppliers across Europe and beyond. (1,173 words)
- [wp-content/uploads/2025/11/uk25-80-01-kent-pharma-order-hub-now-live-a4-flyer-nov-2025-v2-pdf.html](/content/wp-content/uploads/2025/11/uk25-80-01-kent-pharma-order-hub-now-live-a4-flyer-nov-2025-v2-pdf.html) (298 words)
- [wp-content/uploads/2026/06/modern-slavery-and-human-trafficking-statement_2026-part-1-signed-pdf.html](/content/wp-content/uploads/2026/06/modern-slavery-and-human-trafficking-statement_2026-part-1-signed-pdf.html) (1,900 words)
- [Kent Pharma UK Ltd Website Privacy Notice - Kent-Athlone Pharma Group](/content/privacy-policy/index.html): This privacy notice tells you what to expect us to do with your personal information. Contact details Email: dpo@kent-athlone.com What information we collect, use, and why We collect or use the following information to provide services and goods, including delivery: We collect or use the following information for the operation of customer accounts and guarantees: […] (856 words)
- [Over-Labelling provider in the UK](/content/commercial-capabilities/over-labelling/index.html): We are a leading Over-Labelling provider in the UK, with a broad range of over 1,200 products, including the Kent-Athlone Pharma Group licensed range of medicines supplied in ready-to-dispense packs. (497 words)
- [Products - Kent-Athlone Pharma Group](/content/products/index.html): We are committed to providing reliable and consistent supplies of high-quality medicines to improve the lives of our community. (414 words)
- [Responsibility](/content/responsibility/index.html): At Kent-Athlone Pharma Group, we are guided by our vision to set a standard in excellence with quality products and services to our partners. (498 words)
- [News - Kent-Athlone Pharma Group](/content/news/index.html) (389 words)
- [Terms and Conditions - Kent-Athlone Pharma Group](/content/terms-and-conditions/index.html): This website belongs to Kent-Athlone Pharma Group. The information provided on this site is intended for general information and education and is not intended to be a substitute for advice provided by a doctor or other qualified healthcare professional. Kent-Athlone Pharma Group, (KAPG), maintains this site (the “Site”) for your personal information, education, and communication. […] (1,112 words)
- [Cookie Policy - Kent-Athlone Pharma Group](/content/cookie-policy/index.html): 1. Our Policy A cookie is a small file containing an identifier (a series of letters and numbers) sent by a web server to your web browser. The browser will store this file, and each time the browser requests a page from the server (i.e. you click on a page on our website) the identifier […] (856 words)
- [wp-content/uploads/2024/09/uk201202-kent-ready-to-dispense-flyer-july2024-online-pdf.html](/content/wp-content/uploads/2024/09/uk201202-kent-ready-to-dispense-flyer-july2024-online-pdf.html) (560 words)
- [Contact - Non HCP - Kent-Athlone Pharma Group](/content/contact-non-hcp/index.html) (240 words)
- [Contact - HCP - Kent-Athlone Pharma Group](/content/contact-hcp/index.html) (177 words)
- [UK Pharmaceutical Wholesale](/content/commercial-capabilities/wholesale/index.html): We have a wealth of experience in the UK pharmaceutical wholesale and retail pharmacy market, allowing us to gain a thorough understanding of our customers' needs. (185 words)
- [UK Hospital Products](/content/commercial-capabilities/hospital-solutions/index.html): We work closely with our global partners to ensure the consistent supply of a wide range of hospital products, including: Anaesthetics, Anti-Coagulants, Analgesics, Anti-Infectives, Emergency Medicines & Oncology Medicines (318 words)
- [Athlone Pharmaceuticals - Serving Hospitals & Retail Pharmacies in Ireland.](/content/commercial-capabilities/athlone-pharmaceuticals/index.html): Our focus is on Anti-infectives and Oncology Medicines, whilst the broader portfolio contains other products including Anaesthetics and Vitamins. (205 words)
- [People & Culture - Kent-Athlone Pharma Group](/content/people-culture/index.html): A dedicated team focused on delivering value-added and essential medicines to enhance patient care and outcomes. (243 words)
- [contact-athlone-pharmaceuticals/index.html](/content/contact-athlone-pharmaceuticals/index.html) (143 words)
- [career-opportunities/index.html](/content/career-opportunities/index.html) (176 words)
- [Career Opportunities - Kent-Athlone Pharma Group](/content/people-culture/career-opportunities/index.html): As a specialty European pharmaceutical company with offices and production sites in the UK and Ireland, and a strong focus on international growth, we invite committed talents to join us in our transformative journey. (170 words)
- [Kent Pharma Achieves EcoVadis Gold Rating for the Third Consecutive Year - Kent-Athlone Pharma Group](/content/kent-pharma-achieves-ecovadis-gold-rating-for-the-third-consecutive-year.html): The Kent-Athlone Pharma Group, a leading and rapidly growing specialty pharmaceutical company operating across UK and Europe, is pleased to announce that Kent Pharma has been awarded the prestigious EcoVadis Gold Rating for the third consecutive year. (289 words, Jun 3, 2026)
- [Kent-Athlone Pharma Group signs charter for Mindful Employer](/content/kent-athlone-pharma-group-signs-charter-for-mindful-employer.html): Kent-Athlone Pharma Group signs the Mindful Employer Charter, strengthening its commitment to workplace wellbeing, mental health support and inclusion. (297 words, Apr 28, 2026)
- [Kent Pharma Earns Great Place to Work Certification for the Second Consecutive Year - Kent-Athlone Pharma Group](/content/kent-pharma-earns-great-place-to-work-certification-for-the-second-consecutive-year.html): The Kent-Athlone Pharma Group, a rapidly growing specialty European pharmaceuticals company, is proud to announce that Kent Pharma has once again been awarded the Great Place to Work Certification in 2025 for the second consecutive year. (283 words, Jan 12, 2026)
- [Delbert Pharma and Kent-Athlone Pharma Group announce partnership for the Distribution of the injectable aztreonam (Azactam®) in the UK and Ireland - Kent-Athlone Pharma Group](/content/delbert-pharma-kent-athlone-pharma-group-announce-partnership-aztreonam-uk-ie.html): Delbert Pharma, a French pharmaceutical company dedicated to safeguarding essential medicines, announces a partnership with the Kent-Athlone Pharma Group for the Distribution and Marketing of the injectable aztreonam (Azactam®) in the UK and Ireland. "Partnering with Kent-Athlone Pharma Group marks a significant step in Delbert Pharma’s international growth strategy. We are proud to bring Azactam® […] (339 words, Jan 9, 2026)
- [Kent-Athlone Pharma Group Appoints Jon Williams as Wholesale Director - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-appoints-jon-williams-as-wholesale-director.html): Kent-Athlone Pharma Group, a rapidly growing specialty European pharmaceuticals company, is pleased to announce the appointment of Jon Williams as Wholesale Director. (174 words, Dec 15, 2025)
- [Kent-Athlone Pharma Group divests Athlone Laboratories to Gaelic Laboratories - Kent-Athlone Pharma Group](/content/kapg-divests-athlone-laboratories-gaelic-laboratories.html): Kent-Athlone Pharma Group divests Athlone Laboratories to Gaelic Laboratories LONDON/DUBLIN – Kent-Athlone Pharma Group, a European specialty pharmaceutical company, today announced the signing and closing of an agreement for the divestment of the entire issued share capital of Athlone Laboratories Limited, an Irish manufacturer of oral antibiotic finished dosage forms (FDFs), from Linnum Holdings (a […] (771 words, Dec 11, 2025)
- [Kent Pharma launches KENT ORDERHUB: a new online platform for Over-labelled medicines  - Kent-Athlone Pharma Group](/content/online-platform-for-over-labelled-medicines/index.html): The Kent-Athlone Pharma Group, a rapidly growing specialty European pharmaceuticals company, is proud to announce that Kent Pharma has officially launched KENT ORDERHUB: a new online platform for Over-labelled medicines. (181 words, Dec 2, 2025)
- [Kent-Athlone Pharma Group Appoints Olga Lund as Chief Financial Officer - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-appoints-olga-lund-as-chief-financial-officer.html): Kent-Athlone Pharma Group, a rapidly growing specialty European pharmaceuticals company, is pleased to announce the appointment of Olga Lund as Chief Financial Officer (CFO) (207 words, Sep 12, 2025)
- [Kent-Athlone Pharma Group Joins Medicines for Europe as a Company Member as it prepares for commercial expansion in Continental Europe - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-joins-medicines-for-europe-as-a-company-member-as-it-prepares-for-commercial-expansion-in-continental-europe.html): The Kent-Athlone Pharma Group, a rapidly expanding specialty pharmaceuticals company, is pleased to announce that the Company has become a full member of Medicines for Europe. (512 words, Apr 25, 2025)
- [Kent Pharma Earns EcoVadis Gold Rating for the 2nd Year running](/content/kent-pharma-earns-ecovadis-gold-rating-for-the-2nd-year-running.html): The Kent-Athlone Pharma Group, a rapidly growing specialty European pharmaceuticals company, is proud to announce that Kent Pharma has been awarded a Gold Rating by EcoVadis for the second consecutive year. (272 words, Apr 4, 2025)
- [Kent Pharma Awarded Great Place to Work 2024 Certification - Kent-Athlone Pharma Group](/content/kent-pharma-awarded-great-place-to-work-2024-certification.html): Continuing to invest in our positive “One Team” company culture. (309 words, Dec 3, 2024)
- [Kent Athlone Group to improve availability of essential medicines with RELEX Solution - Kent-Athlone Pharma Group](/content/kent-athlone-group-to-improve-availability-of-essential-medicines-with-relex-solution.html): Kent-Athlone Pharma Group has partnered with RELEX Solutions to optimize its supply chain processes and improve the availability of essential medicines. (179 words, Sep 4, 2024)
- [Responding to the Ever-Changing Needs in Healthcare with Consistent Access to Medicines - Kent-Athlone Pharma Group](/content/responding-to-the-ever-changing-needs-in-healthcare-with-consistent-access-to-medicines.html): Kent-Athlone Pharma Group's CEO, Terry Petersen, discusses the company's growth and strategic direction in a recent interview with CEO Monthly. (195 words, Sep 4, 2024)
- [Kent-Athlone Pharma Group and DHL Supply Chain - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-and-dhl-supply-chain/index.html): A Strategic Partnership for Operational Excellence and Supply Chain Optimization to support double-digit annual growth. (478 words, Aug 20, 2024)
- [Kent-Athlone Pharma Group named in Best Places to Work 2024. - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-places-in-sunday-times-best-places-to-work-2024.html): Kent-Athlone Pharma Group, a European Specialty Pharmaceutical company, has been named as a “Best Place to Work” by the Sunday Times Best Places to Work in the medium-sized organisation category Best Places To Work 2024 - The Times & The Sunday Times. (313 words, Aug 20, 2024)
- [Kent-Athlone Pharma Group secured Gold EcoVadis Sustainability Rating - Kent-Athlone Pharma Group](/content/kent-athlone-pharma-group-secured-gold-ecovadis-sustainability-rating.html): Kent-Athlone Pharma Group, a European Speciality Pharmaceutical company has secured a Gold Sustainability Rating from EcoVadis, following an assessment completed in December 2023. (379 words, Aug 20, 2024)

## About Pages

- [Contact - Kent-Athlone Pharma Group](/content/contact/index.html) (136 words)

## Resources

- [Full Page Index](/index.html): Browse all cached pages with rich metadata
- [About This Cache](/about.html): Methodology, technical details, and usage guidelines
- [XML Sitemap](/sitemap.xml): Machine-readable sitemap for crawler discovery
- [Robots.txt](/robots.txt): Crawler directives
- [AgentSite Network](https://agentsite.network/network.html): Public index of AgentSites and their machine-readable resources